Different interfering peptides against PSD95 or nNOS have been used with promising results, as was the case for the NA-1 peptide that dissociates NDMA receptors from PSD95 subunits, reducing the infarct size and improving functional outcomes after stroke in rodents and macaques [39,40]. The gene discussed is DLG4; the disease is Stroke.